Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $442.9600 (-0.94%) ($441.0400 - $449.7400) on Fri. Oct. 13, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.76% (three month average) | | RSI | 56 | | Latest Price | $442.9600(-0.94%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.6% a week on average for past two weeks. | | Market Behavior | Growth stock rally for large cap. Growth stock sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) QQQ(43%) XBI(43%) | | Factors Impacting REGN price | REGN will decline at least -0.88% in a week (0% probabilities).
UUP(-10%) VIXM(-7%) TLT(-6%) TIP(-1%) SHY(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.88% (StdDev 1.76%) | | Hourly BBV | 0 () | | Intraday Trend | -1.2% | | | | | |
|
| Resistance Level | $447.68 | | 5 Day Moving Average | $454.75(-2.59%) | | 10 Day Moving Average | $457.82(-3.25%) | | 20 Day Moving Average | $447.68(-1.05%) | | To recent high | -15% | | To recent low | 2.7% | | Market Cap | $46.966b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |